Skip to main content
Erschienen in: Current Treatment Options in Gastroenterology 2/2022

29.04.2022 | Geriatrics (A Afzali and S Katz, Section Editors)

Endoscopic Bariatric Procedures and the Elderly

verfasst von: Divya Chalikonda, Austin Chiang

Erschienen in: Current Treatment Options in Gastroenterology | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose of review

Obesity is an increasingly prevalent disease among patients greater than age 65. Bariatric procedures offer a promising route to treat obesity in this population. Endoscopic bariatric therapy (EBT) is a promising technique with less risk than surgery. Minimal data exist on the role of EBT in the elderly population. We aim to summarize available literature to make recommendations on procedural considerations and discuss areas for further development.

Recent findings

Existing EBT has largely been studied in a middle-aged population with very few patients above age 65 in pivotal trials. There are several comorbidities frequently encountered in the population evaluated for these procedures, and such conditions warrant a multidisciplinary approach to planning. Specific pre-, intra-, and post-procedure considerations should be given to the elderly population undergoing EBT to optimize the results of the procedure.

Summary

EBT in the elderly population requires more considerations and interdisciplinary planning than procedures in younger counterparts. Given the burden of obesity in this population, there is room for the development of this field, which has the potential to offer life-altering treatment for many.
Literatur
1.
Zurück zum Zitat Fakhouri TH, Ogden CL, Carroll MD, et al. Prevalence of obesity among older adults in the United States, 2007–2010. NCHS data brief, no 106. Hyattsville, MD: National Center for Health Statistics. 2012. Fakhouri TH, Ogden CL, Carroll MD, et al. Prevalence of obesity among older adults in the United States, 2007–2010. NCHS data brief, no 106. Hyattsville, MD: National Center for Health Statistics. 2012.
2.•
Zurück zum Zitat Batsis JA, Zagaria AB. Addressing obesity in aging patients. Medical Clinics. 2018;102(1):65–85. This article captures the impact of an increasingly obese population among the elderly. It highlights that as these individuals live longer, they are more suscept to have complications of comorbidities related to obesity and recommends consideration of bariatric surgery despite age. It highlights the need for further options in obesity management among the elderly population.PubMed Batsis JA, Zagaria AB. Addressing obesity in aging patients. Medical Clinics. 2018;102(1):65–85. This article captures the impact of an increasingly obese population among the elderly. It highlights that as these individuals live longer, they are more suscept to have complications of comorbidities related to obesity and recommends consideration of bariatric surgery despite age. It highlights the need for further options in obesity management among the elderly population.PubMed
3.
Zurück zum Zitat Vinan-Vega M, Vico TD, Elli EF. Bariatric surgery in the elderly patient: safety and short-time outcome. A case match analysis Obesity surgery. 2019;29(3):1007–11.CrossRef Vinan-Vega M, Vico TD, Elli EF. Bariatric surgery in the elderly patient: safety and short-time outcome. A case match analysis Obesity surgery. 2019;29(3):1007–11.CrossRef
4.
Zurück zum Zitat Koh CY, Inaba CS, Sujatha-Bhaskar S, Nguyen NT. Outcomes of laparoscopic bariatric surgery in the elderly population. Am Surg. 2018;84(10):1600–3.CrossRef Koh CY, Inaba CS, Sujatha-Bhaskar S, Nguyen NT. Outcomes of laparoscopic bariatric surgery in the elderly population. Am Surg. 2018;84(10):1600–3.CrossRef
5.
Zurück zum Zitat Dayyeh BK, Edmundowicz SA, Jonnalagadda S, Kumar N, Larsen M, Sullivan S, Thompson CC, Banerjee S. Endoscopic bariatric therapies. Gastrointest Endosc. 2015;81(5):1073–86.CrossRef Dayyeh BK, Edmundowicz SA, Jonnalagadda S, Kumar N, Larsen M, Sullivan S, Thompson CC, Banerjee S. Endoscopic bariatric therapies. Gastrointest Endosc. 2015;81(5):1073–86.CrossRef
7.
Zurück zum Zitat Kumar N, Bazerbachi F, Rustagi T, McCarty TR, Thompson CC, Neto MP, Zundel N, Wilson EB, Gostout CJ, Dayyeh BK. The influence of the Orbera intragastric balloon filling volumes on weight loss, tolerability, and adverse events: a systematic review and meta-analysis. Obes Surg. 2017;27(9):2272–8.CrossRef Kumar N, Bazerbachi F, Rustagi T, McCarty TR, Thompson CC, Neto MP, Zundel N, Wilson EB, Gostout CJ, Dayyeh BK. The influence of the Orbera intragastric balloon filling volumes on weight loss, tolerability, and adverse events: a systematic review and meta-analysis. Obes Surg. 2017;27(9):2272–8.CrossRef
8.••
Zurück zum Zitat Singh S, de Moura DT, Khan A, Bilal M, Ryan MB, Thompson CC. Safety and efficacy of endoscopic sleeve gastroplasty worldwide for treatment of obesity: a systematic review and meta-analysis. Surgery for Obesity and Related Diseases. 2020;16(2):340–51. This is one of few systematic reviews on a specific type of EBT, ESG, and incorporates data from international centers. It is pivotal in that it evaluates one of the most invasive forms of EBT, though still demonstrates the safety and efficacy of this weight loss option. Despite an average age less than that defined as elderly in this article, it highlights the possibilities advances in EBT offer.CrossRef Singh S, de Moura DT, Khan A, Bilal M, Ryan MB, Thompson CC. Safety and efficacy of endoscopic sleeve gastroplasty worldwide for treatment of obesity: a systematic review and meta-analysis. Surgery for Obesity and Related Diseases. 2020;16(2):340–51. This is one of few systematic reviews on a specific type of EBT, ESG, and incorporates data from international centers. It is pivotal in that it evaluates one of the most invasive forms of EBT, though still demonstrates the safety and efficacy of this weight loss option. Despite an average age less than that defined as elderly in this article, it highlights the possibilities advances in EBT offer.CrossRef
9.
Zurück zum Zitat Bastos EC, Barbosa EM, Soriano GM, Santos EA, Vasconcelos SM. Determinants of weight regain after bariatric surgery ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo). 2013;26:26–32.CrossRef Bastos EC, Barbosa EM, Soriano GM, Santos EA, Vasconcelos SM. Determinants of weight regain after bariatric surgery ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo). 2013;26:26–32.CrossRef
10.
Zurück zum Zitat Goyal D, Watson RR. Endoscopic bariatric therapies. Curr Gastroenterol Rep. 2016;18(6):26.CrossRef Goyal D, Watson RR. Endoscopic bariatric therapies. Curr Gastroenterol Rep. 2016;18(6):26.CrossRef
11.
Zurück zum Zitat Goyal D. Endoscopic trans-oral outlet reduction in combination with gastroplasty (TORe-G) is a novel technique that is highly efficacious and safe for weight loss in patients with failed Rouxen-Y gastric bypass (RYGB). Los Angeles: University of California; 2016. Goyal D. Endoscopic trans-oral outlet reduction in combination with gastroplasty (TORe-G) is a novel technique that is highly efficacious and safe for weight loss in patients with failed Rouxen-Y gastric bypass (RYGB). Los Angeles: University of California; 2016.
12.
Zurück zum Zitat Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med. 1995;155(5):469–73.CrossRef Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med. 1995;155(5):469–73.CrossRef
13.
Zurück zum Zitat Faller N, Limacher A, Méan M, Righini M, Aschwanden M, Beer JH, Frauchiger B, Osterwalder J, Kucher N, Lämmle B, Cornuz J. Predictors and causes of long-term mortality in elderly patients with acute venous thromboembolism: a prospective cohort study. Am J Med. 2017;130(2):198–206.CrossRef Faller N, Limacher A, Méan M, Righini M, Aschwanden M, Beer JH, Frauchiger B, Osterwalder J, Kucher N, Lämmle B, Cornuz J. Predictors and causes of long-term mortality in elderly patients with acute venous thromboembolism: a prospective cohort study. Am J Med. 2017;130(2):198–206.CrossRef
14.
Zurück zum Zitat Poirier P, Cornier MA, Mazzone T, Stiles S, Cummings S, Klein S, McCullough PA, Ren Fielding C, Franklin BA. Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association. Circulation. 2011;123(15):1683–701.CrossRef Poirier P, Cornier MA, Mazzone T, Stiles S, Cummings S, Klein S, McCullough PA, Ren Fielding C, Franklin BA. Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association. Circulation. 2011;123(15):1683–701.CrossRef
15.
Zurück zum Zitat Gugliotti D, Grant P, Jaber W, Aboussouan L, Bae C, Sessler D, Scahuer P, Kaw R. Challenges in cardiac risk assessment in bariatric surgery patients. Obes Surg. 2008;18(1):129–33.CrossRef Gugliotti D, Grant P, Jaber W, Aboussouan L, Bae C, Sessler D, Scahuer P, Kaw R. Challenges in cardiac risk assessment in bariatric surgery patients. Obes Surg. 2008;18(1):129–33.CrossRef
16.
Zurück zum Zitat Dantas AC, Santo MA, de Cleva R, Sallum RA, Cecconello I. Influence of obesity and bariatric surgery on gastric cancer. Cancer Biol Med. 2016;13(2):269.CrossRef Dantas AC, Santo MA, de Cleva R, Sallum RA, Cecconello I. Influence of obesity and bariatric surgery on gastric cancer. Cancer Biol Med. 2016;13(2):269.CrossRef
17.
Zurück zum Zitat Orlando G, Pilone V, Vitiello A, Gervasi R, Lerose MA, Silecchia G, Puzziello A. Gastric cancer following bariatric surgery: a review. Surgical Laparoscopy Endoscopy & Percutaneous Techniques. 2014;24(5):400–5.CrossRef Orlando G, Pilone V, Vitiello A, Gervasi R, Lerose MA, Silecchia G, Puzziello A. Gastric cancer following bariatric surgery: a review. Surgical Laparoscopy Endoscopy & Percutaneous Techniques. 2014;24(5):400–5.CrossRef
18.
Zurück zum Zitat De Pergola G, Silvestris F. Obesity as a major risk factor for cancer. Journal of obesity. 2013 2013. De Pergola G, Silvestris F. Obesity as a major risk factor for cancer. Journal of obesity. 2013 2013.
19.
Zurück zum Zitat Contreras JE, Santander C, Bravo J. Correlation between age and weight loss after bariatric surgery. Obes Surg. 2013;23(8):1286–9.CrossRef Contreras JE, Santander C, Bravo J. Correlation between age and weight loss after bariatric surgery. Obes Surg. 2013;23(8):1286–9.CrossRef
20.••
Zurück zum Zitat Susmallian S, Raziel A, Barnea R, Paran H. Bariatric surgery in older adults: should there be an age limit? Medicine. 2019 98(3). This article analyzes the outcomes regarding safety and technical success of bariatric surgery in the elderly population. As EBT has similar intended outcomes as surgery, these results are key in understanding whether such procedures are warranted in older patients. It demonstrates that while a small percentage can develop complications, overall outcomes are promising and result in an improved quality of life. Susmallian S, Raziel A, Barnea R, Paran H. Bariatric surgery in older adults: should there be an age limit? Medicine. 2019 98(3). This article analyzes the outcomes regarding safety and technical success of bariatric surgery in the elderly population. As EBT has similar intended outcomes as surgery, these results are key in understanding whether such procedures are warranted in older patients. It demonstrates that while a small percentage can develop complications, overall outcomes are promising and result in an improved quality of life.
21.
Zurück zum Zitat Sugerman HJ, DeMaria EJ, Kellum JM, Sugerman EL, Meador JG, Wolfe LG. Effects of bariatric surgery in older patients. Ann Surg. 2004;240(2):243.CrossRef Sugerman HJ, DeMaria EJ, Kellum JM, Sugerman EL, Meador JG, Wolfe LG. Effects of bariatric surgery in older patients. Ann Surg. 2004;240(2):243.CrossRef
22.
Zurück zum Zitat Ginsberg, G. G., Chand, B., Cote, G. A., Dallal, R. M., Edmundowicz, S. A., Nguyen, N. T., ... & Thompson, C. C. A pathway to endoscopic bariatric therapies. Gastrointestinal endoscopy, 2011 74(5), 943-953 Ginsberg, G. G., Chand, B., Cote, G. A., Dallal, R. M., Edmundowicz, S. A., Nguyen, N. T., ... & Thompson, C. C. A pathway to endoscopic bariatric therapies. Gastrointestinal endoscopy, 2011 74(5), 943-953
23.
Zurück zum Zitat Itani MI, Farha J, Marrache MK, Fayad L, Badurdeen D, Kumbhari V. The effects of bariatric surgery and endoscopic bariatric therapies on GERD: an update. Current treatment options in gastroenterology. 2020;18(1):97–108.CrossRef Itani MI, Farha J, Marrache MK, Fayad L, Badurdeen D, Kumbhari V. The effects of bariatric surgery and endoscopic bariatric therapies on GERD: an update. Current treatment options in gastroenterology. 2020;18(1):97–108.CrossRef
24.
Zurück zum Zitat Sullivan S, Kumar N, Edmundowicz SA, Dayyeh BKA, Jonnalagadda SS, Larsen M, Thompson CC. ASGE position statement on endoscopic bariatric therapies in clinical practice. Gastrointest Endosc. 2015;82(5):767–72.CrossRef Sullivan S, Kumar N, Edmundowicz SA, Dayyeh BKA, Jonnalagadda SS, Larsen M, Thompson CC. ASGE position statement on endoscopic bariatric therapies in clinical practice. Gastrointest Endosc. 2015;82(5):767–72.CrossRef
25.
Zurück zum Zitat Hart, A., Lentine, K. L., Smith, J. M., Miller, J. M., Skeans, M. A., Prentice, M., ... & Snyder, J. J. OPTN/SRTR 2019 annual data report: kidney. American Journal of Transplantation, 2021 21, 21-137 Hart, A., Lentine, K. L., Smith, J. M., Miller, J. M., Skeans, M. A., Prentice, M., ... & Snyder, J. J. OPTN/SRTR 2019 annual data report: kidney. American Journal of Transplantation, 2021 21, 21-137
26.
Zurück zum Zitat Kwong, A. J., Kim, W. R., Lake, J. R., Smith, J. M., Schladt, D. P., Skeans, M. A., ... & Kasiske, B. L. OPTN/SRTR 2019 annual data report: liver. American Journal of Transplantation, 2021 21, 208-315 Kwong, A. J., Kim, W. R., Lake, J. R., Smith, J. M., Schladt, D. P., Skeans, M. A., ... & Kasiske, B. L. OPTN/SRTR 2019 annual data report: liver. American Journal of Transplantation, 2021 21, 208-315
27.
Zurück zum Zitat Wadden TA, Foreyt JP, Foster GD, Hill JO, Klein S, O’neil PM, Perri MG, Pi‐Sunyer FX, Rock CL, Erickson JS, Maier HN. Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification the COR‐BMOD trial. Obesity. 2011;19(1):110–20.CrossRef Wadden TA, Foreyt JP, Foster GD, Hill JO, Klein S, O’neil PM, Perri MG, Pi‐Sunyer FX, Rock CL, Erickson JS, Maier HN. Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification the COR‐BMOD trial. Obesity. 2011;19(1):110–20.CrossRef
28.
Zurück zum Zitat Wadden TA, Sarwer DB. Behavioral assessment of candidates for bariatric surgery: a patient-oriented approach. Surgery for Obesity and Related Diseases. 2006;2(2):171–9.CrossRef Wadden TA, Sarwer DB. Behavioral assessment of candidates for bariatric surgery: a patient-oriented approach. Surgery for Obesity and Related Diseases. 2006;2(2):171–9.CrossRef
29.
Zurück zum Zitat O’Neil PM, Birkenfeld AL, McGowan B, Mosenzon O, Pedersen SD, Wharton S, Carson CG, Jepsen CH, Kabisch M, Wilding JP. Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. The Lancet. 2018;392(10148):637–49.CrossRef O’Neil PM, Birkenfeld AL, McGowan B, Mosenzon O, Pedersen SD, Wharton S, Carson CG, Jepsen CH, Kabisch M, Wilding JP. Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. The Lancet. 2018;392(10148):637–49.CrossRef
30.
Zurück zum Zitat Lohsiriwat V. Colonoscopic perforation: incidence, risk factors, management and outcome. World J Gastroenterol: WJG. 2010;16(4):425.CrossRef Lohsiriwat V. Colonoscopic perforation: incidence, risk factors, management and outcome. World J Gastroenterol: WJG. 2010;16(4):425.CrossRef
31.
Zurück zum Zitat Merchea, A., Cullinane, D. C., Sawyer, M. D., Iqbal, C. W., Baron, T. H., Wigle, D., ... & Zielinski, M. D. Esophagogastroduodenoscopy-associated gastrointestinal perforations: a single-center experience. Surgery, 2010 148(4), 876-882 Merchea, A., Cullinane, D. C., Sawyer, M. D., Iqbal, C. W., Baron, T. H., Wigle, D., ... & Zielinski, M. D. Esophagogastroduodenoscopy-associated gastrointestinal perforations: a single-center experience. Surgery, 2010 148(4), 876-882
32.
Zurück zum Zitat Kwiatt K, Chaaya A, Andonakakis A. Anesthesia for endoscopic bariatric surgery. Anaesthesia for Uncommon and Emerging Procedures. 2021:1–0. Kwiatt K, Chaaya A, Andonakakis A. Anesthesia for endoscopic bariatric surgery. Anaesthesia for Uncommon and Emerging Procedures. 2021:1–0.
Metadaten
Titel
Endoscopic Bariatric Procedures and the Elderly
verfasst von
Divya Chalikonda
Austin Chiang
Publikationsdatum
29.04.2022
Verlag
Springer US
Erschienen in
Current Treatment Options in Gastroenterology / Ausgabe 2/2022
Print ISSN: 1092-8472
Elektronische ISSN: 1534-309X
DOI
https://doi.org/10.1007/s11938-022-00376-z

Weitere Artikel der Ausgabe 2/2022

Current Treatment Options in Gastroenterology 2/2022 Zur Ausgabe

Endoscopy (P Siersema, Section Editor)

Prevention of Duodenoscope-Associated Infections

Genetics in Gastroenterology Practice (BW Katona, Section Editor)

Incidental Young-Onset Adenomas: Sporadic Findings or Harbingers of Increased Colon Cancer Risk?

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.